Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06303505
Title FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC (NAPISTAR1-01)
Acronym NAPISTAR1-01
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Tubulis GmbH
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ESP | DEU | BEL


No variant requirements are available.